MedTrace Logo

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

NCT01705704 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 269

Last updated 2016-11-02

No results posted yet for this study

Summary

This retrospective study will evaluate the association of biomarkers and the treatment response of patients with chronic hepatitis B, who have completed therapy with Pegasys (peginterferon alfa-2a) ± lamivudine. For the analysis stored serum samples obtained from patients will be used; no actual patients are involved.

Conditions

  • Hepatitis B, Chronic

Sponsors & Collaborators

Principal Investigators

  • Clinical Trials · Hoffmann-La Roche

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • Australia
  • France
  • Hong Kong
  • Italy
  • New Zealand
  • Russia
  • Singapore
  • South Korea
  • Taiwan
  • Thailand

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01705704 on ClinicalTrials.gov